Ticker

BGM Group Ltd. (NASDAQ: BGM - Get Free Report) was the target of a significant decline in short interest in the month of February. As of February 27th, there was short interest totaling 65,241 shares, a decline of 13.0% from the February 12th total of 74,988 shares. Currently, 0.2% of the shares of the company are

CHENGDU, China, Feb. 26, 2026 (GLOBE NEWSWIRE) -- BGM Group Ltd. (NASDAQ: BGM) (the “Company” or “BGM”)  announced on February 24, 2026, that it has received a notification (the “Notification”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) regarding its non-compliance with the Nasdaq Listing Rule 5250 (c)(1) as a result of the Company's failure to file its Annual Report on Form…

Shares of BGM Group Ltd. (NASDAQ: BGM - Get Free Report) fell 1% during mid-day trading on Friday. The stock traded as low as $1.02 and last traded at $1.04. 32,715 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 111,259 shares. The stock had previously closed at

Rhythm Pharmaceuticals (NASDAQ: RYTM - Get Free Report) and BGM Group (NASDAQ: BGM - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability. Analyst Ratings This is a summary of current